Trial Profile
Pharmacokinetics, safety and tolerability of agalsidase beta in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Oct 2015
Price :
$35
*
At a glance
- Drugs Agalsidase beta (Primary)
- Indications Fabry's disease
- Focus Adverse reactions; First in man; Pharmacokinetics
- 27 Oct 2015 New trial record